CEO Steven Basta told attendees at the Guggenheim Emerging Outlook Biotech Summit 2026 that the company’s commercial focus over the past year has shifted more heavily toward gastroenterology, a move h ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results